1-5 of 5
Mette Matilda Ilander, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD PhD, Hanna Lähteenmäki, MSc, Kasanen Tiina, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Höglund, MDPhD, Berit Markevärn, MD, Anders Själander, MD PhD, Kourosh Lotfi, MDPhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD PhD, Leif Stenke, MD PhD, Lotta Ohm, MD PhD, Waleed Majeed, MD, Markus Pfirrmann, PhD, Martin C Muller, MD, Joelle Guilhot, PhD, Hans Ehrencrona, MD PhD, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD, Kimmo Porkka, MD PhD, Johan Richter, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 812.
https://doi.org/10.1182/blood.V124.21.812.812
Published: 2014
Journal Articles

Dasatinib-Induced Reduction of Tumor Growth Is Accompanied By the Changes in the Immune Profile in a Melanoma B16.OVA Mouse Model

Mette Matilda Ilander, MSc, Can Hekim, PhD, Markus Vähä-Koskela, PhD, Paula Savola, Siri Tähtinen, MSc, Leena Saikko, Akseli Hemminki, MDPhD, Panu Kovanen, MDPhD, Kimmo Porkka, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1408.
https://doi.org/10.1182/blood.V124.21.1408.1408
Published: 2014
Journal Articles

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD, PhD, Hanna Lähteenmäki, MSc, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Hoglund, MD, PhD, Berit Markevärn, MD, Anders Själander, MD, PhD, Kourosh Lofti, MD, PhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD, PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD, PhD, Leif Stenke, MD, PhD, Lotta Ohm, MD, Henrik Hjorth-Hansen, MD, PhD, Susanne Saussele, MD, Francois-Xavier Mahon, MD, PhD, Kimmo Porkka, MD, PhD, Johan Richter, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 379.
https://doi.org/10.1182/blood.V122.21.379.379
Published: 2013
Journal Articles

Functional Characterization of T- and NK-Cells in Chronic Myeloid Leukemia Patients Treated with Interferon-α Monotherapy.

Mette Matilda Ilander, MSc, Anna Kreutzman, PhD, Peter Rohon, MD, Teresa Melo, MD, Edgar Faber, MD, PhD, Kimmo Porkka, MD, PhD, Jukka Vakkila, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2782.
https://doi.org/10.1182/blood.V120.21.2782.2782
Published: 2012
Journal Articles

Chronic Myeloid Leukemia Patients Undergoing Interferon Alpha Therapy Exhibit Normal Peripheral Blood Gamma Delta T Cells That May Be Expanded in Vitro to Generate Predominantly CD45RA-Positive Effector Memory Cells for Immunotherapy

Gabrielle Melanie Siegers, PhD, Anna Kreutzman, PhD, Mette Matilda Ilander, MSc, Satu Mustjoki, MD, PhD, Lynne Marie Postovit, PhD
Journal: Blood
Blood (2012) 120 (21): 3729.
https://doi.org/10.1182/blood.V120.21.3729.3729
Published: 2012